Nicole Basta: Updated Evidence for Covid-19, RSV, and Influenza Vaccines for 2025–2026
Nicole Basta, Associate Professor of Epidemiology at McGill University, shared a post on LinkedIn about a paper by Jake Scott et al. published in NEJM:
“Wondering if it’s worth it to get a Flu, COVID-19, and/or RSV shot this year?
We did the research, so you don’t have to! And the answer is – Yes, it’s worth it!
Our review of over 500 of the most recently published studies revealed important benefits of these vaccines, including:
- Flu vaccination can reduce the risk of hospitalization by nearly 70% in children and by about 50% in adults, including adults 65 yrs and older (with high-dose vaccine).
- COVID-19 vaccination can reduce the risk of hospitalization by about half among all adults, including older adults. Adults with immunocompromising conditions can also benefit with the risk of hospitalization reduced by just under 40%.
- RSV vaccination during pregnancy can reduce the risk of hospitalization for infants by 70%; Similar reduction in risk for vaccinated older adults, as well.
The safety profiles for each of these vaccines continue to demonstrate that serious adverse events are very, very rare.
Check out all of the details for yourself NEJM Group.”
Title: Updated Evidence for Covid-19, RSV, and Influenza Vaccines for 2025–2026
Authors: Jake Scott, Michael S. Abers, Harleen K. Marwah, Nicole C. McCann, Eric A. Meyerowitz, Aaron Richterman, Derek F. Fleming, Elise J. Holmes, Leah E. Moat, Sydney G. Redepenning, Emily A. Smith, Clare J. Stoddart, Maria E. Sundaram, Angela K. Ulrich, Christopher Alba, Cory J. Anderson, Meredith K. Arpey, Ethan Borre, Joseph Ladines-Lim, Angela J. Mehr, Katherine Rich, Corey Watts, Nicole E. Basta, Jana Jarolimova, Rochelle P. Walensky, Caitlin M. Dugdale
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Jan 28, 2026, 16:59Unlocking the Potential of Menstrual Blood in Health Testing – Global Women’s Health Innovation Conclave
-
Jan 28, 2026, 16:57New Insights on Oocyte Yield in Endometriosis and PCOM – RBMO
-
Jan 28, 2026, 16:51Transform Your Expertise with ESHRE eCampus Learning – ESHRE
-
Jan 28, 2026, 16:46Accelerate Your Growth at the AP3G National Meeting – ASRM
-
Jan 28, 2026, 16:43Debojit Saha: Unraveling Chromosomal Errors in Aging Human Eggs
-
Jan 28, 2026, 16:38Silvia Vannuccini: RBMO Highlights Key Insights on Adenomyosis Awareness
-
Jan 28, 2026, 16:32Maximilian Attwood: Challenging Medical Misogyny in Endometriosis Research
-
Jan 28, 2026, 16:29Ioakeim Sapantzoglou: New Perspectives on Fetal Growth Restriction and Genetic Testing
-
Jan 28, 2026, 16:26Enhancing Pre-Eclampsia Prediction with Doppler Indices – ISUOG